Biochemical pharmacology

Keyphrases

Publications

volume 229, 2024

Hsiao-Chi Tsai, Ming-Hsui Tsai, Chun-Hung Hua, Chun-Wei Huang, Chien-Chi Lu, Kwei-Jing Chen, Michael Yuan-Chien Chen, Ming-Yu Lien, Chih-Hsin Tang
Circ_0002722-induced regulation of YAP promotes platinum resistance in oral squamous cell carcinoma: Implications for verteporfin therapy. Biochemical pharmacology 229 (2024)
Ziyou Huai, Zijian Li, Wei Xue, Shujing Li, Yinjiu Huang, Xin Cao, Qinjun Wei, Yuanyuan Wang
Novel curcumin derivatives N17 exert anti-cancer effects through the CSNK1G3/AKT axis in triple-negative breast cancer. Biochemical pharmacology 229 (2024)
Mounia Lakli, Marion Onnée, Thomas Carrez, Frédéric Becq, null Thomas Falguières, Pascale Fanen
ABC transporters involved in respiratory and cholestatic diseases: From rare to very rare monogenic diseases. Biochemical pharmacology 229 (2024)
Zehao Wang, Sisi Yan, Shichong Liao, Yan Zhang, Shujuan Wu, Mengqi Zhou, Wenyi Jin, Yi Zhang, Xinyu Qi, Chaogang Yang, Jing Yang, Jinli Ding
Dysregulated lncSNHG12 suppresses the invasion and migration of trophoblasts by regulating Dio2/Snail axis to involve in recurrent spontaneous abortion. Biochemical pharmacology 229 (2024)
Liesl K Janssens, Christophe P Stove
The 'ABC' of split-nanoluciferase HIF heterodimerization bioassays: Applications, Benefits & Considerations. Biochemical pharmacology 229 (2024)
Radoslav Stojchevski, Sara Velichkovikj, Jane Bogdanov, Nikola Hadzi-Petrushev, Mitko Mladenov, Leonid Poretsky, Dimiter Avtanski
Monocarbonyl analogs of curcumin C66 and B2BrBC modulate oxidative stress, JNK activity, and pancreatic gene expression in rats with streptozotocin-induced diabetes. Biochemical pharmacology 229 (2024)
Tomas Smutny, Lucie Smutna, Lukas Lochman, Rajamanikkam Kamaraj, Radim Kucera, Petr Pavek
Rifampicin and its derivatives: stability, disposition, and affinity towards pregnane X receptor employing 2D and 3D primary human hepatocytes. Biochemical pharmacology 229 (2024)
Qi Zhang, Yanting Zhang, Shiyun Guo, Xiao Wang, Honggang Wang
Hydrogen sulfide plays an important role by regulating microRNA in different ischemia-reperfusion injury. Biochemical pharmacology 229 (2024)
Margarita Espona-Fiedler, Cedric Patthey, Stina Lindblad, Irina Sarró, Daniel Öhlund
Overcoming therapy resistance in pancreatic cancer: New insights and future directions. Biochemical pharmacology 229 (2024)
Elita Yuliantie, Phuc Nh Trinh, Caroline Hick, Rebecca Ebenhoch, Herbert Nar, Dietmar Weichert, Arthur Christopoulos, Patrick M Sexton, Denise Wootten
Isoquinoline small molecule ligands are agonists and probe-dependent allosteric modulators of the glucagon subfamily of GPCRs. Biochemical pharmacology 229 (2024)
Cornel Balta, Hildegard Herman, Alina Ciceu, Caterina Claudia Lepre, Bianca Mladin, Marcel Rosu, Daniela Oatis, Marina Russo, Victor Eduard Peteu, Mihaela Gherghiceanu, Ferenc Fenyvesi, Coralia Cotoraci, Maria Consiglia Trotta, Michele D'Amico, Anca Hermenean
Chrysin-loaded calixarene-cyclodextrin ternary drug delivery system inhibits TGF-β and galectin-1 mediated pathways in diabetic liver fibrosis. Biochemical pharmacology 229 (2024)
Shuai Chen, Qingqing He, Huaiyu Yang, Hongxing Huang
Endothelial Birc3 promotes renal fibrosis through modulating Drp1-mediated mitochondrial fission via MAPK/PI3K/Akt pathway. Biochemical pharmacology 229 (2024)
Estera Rintz, Maja Ziemian, Barbara Kobus, Lidia Gaffke, Karolina Pierzynowska, Grzegorz Wegrzyn
Synergistic effects of resveratrol and enzyme replacement therapy in the Mucopolysaccharidosis type I. Biochemical pharmacology 229 (2024)
Xiaodan Zhang, Lihong Zhou, Yulong Peng, Shiyu He, Zhen Mao, Jin Cai, Aobo Geng, Hong Yang, Peili Huang
Melatonin alleviates brain injury in copper-laden rats: Underlying benefits for Wilson's disease. Biochemical pharmacology 229 (2024)
Qinwei Zhu, Liyang Du, Juhong Wu, Jinyu Li, Zhonghui Lin
Walrycin B, as a novel separase inhibitor, exerts potent anticancer efficacy in a mouse xenograft model. Biochemical pharmacology 229 (2024)
Mounia Lakli, Marion Onnée, Thomas Carrez, Frédéric Becq, Thomas Falguières, Pascale Fanen
ABC transporters involved in respiratory and cholestatic diseases: From rare to very rare monogenic diseases. Biochemical pharmacology 229 (2024)
Noha F Hassan, Mona R El-Ansary, Amira R El-Ansary, Mohamed A El-Saied, Omnia S Zaki
Unveiling the protective potential of mirabegron against thioacetamide-induced hepatic encephalopathy in rats: Insights into cAMP/PPAR-γ/p-ERK1/2/p S536 NF-κB p 65 and p-CREB/BDNF/TrkB in parallel with oxidative and apoptotic trajectories. Biochemical pharmacology 229 (2024)
Kristof De Vos, Adamantios Mavrogiannis, Justina Clarinda Wolters, Susan Schlenner, Keimpe Wierda, Álvaro Cortés Calabuig, Reena Chinnaraj, Vera Dermesrobian, Yeghig Armoudjian, Maarten Jacquemyn, Nikky Corthout, Dirk Daelemans, Pieter Annaert
Corrigendum to "Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells" [Biochem. Pharmacol. 227 (2024) 116445]. Biochemical pharmacology 229 (2024)
Christiana Mo, Ning Wei, Terence Li, Muzaffer Ahmed Bhat, Mahshid Mohammadi, Chaoyuan Kuang
CDK9 inhibitors for the treatment of solid tumors. Biochemical pharmacology 229 (2024)
Christiana Mo, Ning Wei, Terence Li, Muzaffer Ahmed Bhat, Mahshid Mohammadi, Chaoyuan Kuang
CDK9 inhibitors for the treatment of solid tumors. Biochemical pharmacology 229 (2024)
Weibin He, Wenlong He, Xiaopan Chen, Lin Zeng, Lihuan Zeng, Yuanhui Liu, Pengcheng He, Zhongchan Sun
Mitochondrial elongation confers protection against doxorubicin-induced cardiotoxicity. Biochemical pharmacology 229 (2024)
Laura Herrero
Adipose tissue in health and disease. Biochemical pharmacology 229 (2024)
Zhanzhan Feng, Wei Wei, Shirui Wang, Xiao Li, Lifeng Zhao, Guoquan Wan, Rong Hu, Luoting Yu
A novel selective FAK inhibitor E2 inhibits ovarian cancer metastasis and growth by inducing cytotoxic autophagy. Biochemical pharmacology 229 (2024)
Natalia L Rukavina Mikusic, Mauro G Silva, Fernando A Erra Díaz, Angélica M Pineda, Fátima Ferragut, Karina A Gómez, Luciana Mazzitelli, Daniel H Gonzalez Maglio, Myriam Nuñez, Robson A S Santos, Hernán E Grecco, Mariela M Gironacci
Alamandine, a protective component of the renin-angiotensin system, reduces cellular proliferation and interleukin-6 secretion in human macrophages through MasR-MrgDR heteromerization. Biochemical pharmacology 229 (2024)
Mingyue Tan, Yunfei Yin, Weixiang Chen, Jun Zhang, Yifeng Jin, Yue Zhang, Lei Zhang, Tingbo Jiang, Bin Jiang, Hongxia Li
Trimetazidine attenuates Ischemia/Reperfusion-Induced myocardial ferroptosis by modulating the Sirt3/Nrf2-GSH system and reducing Oxidative/Nitrative stress. Biochemical pharmacology 229 (2024)
Somayyeh Ghareghomi, Payam Arghavani, Majid Mahdavi, Ali Khatibi, Custodia García-Jiménez, Ali A Moosavi-Movahedi
Hyperglycemia-driven signaling bridges between diabetes and cancer. Biochemical pharmacology 229 (2024)
Shan Meng, Xin Chen, Jikai Zhao, Xinyi Huang, Yuting Huang, Tao Huang, Zijun Zhou, Wenpu Ren, Tao Hong, Jinfeng Duan, Liming Yu, Huishan Wang
Reduced FNDC5-AMPK signaling in diabetic atrium increases the susceptibility of atrial fibrillation by impairing mitochondrial dynamics and activating NLRP3 inflammasome. Biochemical pharmacology 229 (2024)
Zixinying Han, Chenxu Liu, Mingrui Li, Mengyan Deng, Ying Ding, Yunchao Li, Meidan Huo, Haiwei Xu, Hailing Qiao, Na Gao
Discovery of CYP2E1 as a novel target in rheumatoid arthritis and validation by a new specific CYP2E1 inhibitor. Biochemical pharmacology 229 (2024)
Anatoly Soloviev, Vadym Kozlowsky, Vadym Sydorenko, Irina Ivanova, Dariia Samofalova, Vladimir Fetyukhin
Citrulline activates adenosine receptors: New insight into metabolic pathways interaction. Biochemical pharmacology 229 (2024)
Arun George Devasia, Meyammai Shanmugham, Adaikalavan Ramasamy, Sophie Bellanger, Laura J Parry, Chen Huei Leo
Therapeutic potential of relaxin or relaxin mimetics in managing cardiovascular complications of diabetes. Biochemical pharmacology 229 (2024)
Julia Maria Frare, Patrícia Rodrigues, Náthaly Andrighetto Ruviaro, Gabriela Trevisan
Chronic post-ischemic pain (CPIP) a model of complex regional pain syndrome (CRPS-I): Role of oxidative stress and inflammation. Biochemical pharmacology 229 (2024)
Thu-Hang Nguyen, Hoang-Hanh-Nhan Nguyen, Thuy-Duong Nguyen, Van Thi-Hong Tran, Hoang-Anh Nguyen, Duc-Vinh Pham
NLRP3 inflammasome activation contributes to the development of the pro-fibrotic phenotype of lung fibroblasts. Biochemical pharmacology 229 (2024)
Alain Arias-Betancur, Pere Fontova, Daniel Alonso-Carrillo, Israel Carreira-Barral, Janneke Duis, María García-Valverde, Vanessa Soto-Cerrato, Roberto Quesada, Ricardo Pérez-Tomás
Deregulation of lactate permeability using a small-molecule transporter (Lactrans-1) disturbs intracellular pH and triggers cancer cell death. Biochemical pharmacology 229 (2024)
Huihui Chen, Jie Song, Li Zeng, Jie Zha, Jiefu Zhu, Anqun Chen, Yu Liu, Zheng Dong, Guochun Chen
Dietary sodium modulates mTORC1-dependent trained immunity in macrophages to accelerate CKD development. Biochemical pharmacology 229 (2024)
Zhizhong Wang, Wenjing Ding, Daning Shi, Xiaoling Chen, Chengbang Ma, Yangyang Jiang, Tao Wang, Tianbao Chen, Chris Shaw, Lei Wang, Mei Zhou
Functional characterisation and modification of a novel Kunitzin peptide for use as an anti-trypsin antimicrobial peptide against drug-resistant Escherichia coli. Biochemical pharmacology 229 (2024)
Pankaj Garg, Sravani K Ramisetty, Ayalur Raghu Subbalakshmi, B Madhu Krishna, Siddhika Pareek, Atish Mohanty, Prakash Kulkarni, David Horne, Ravi Salgia, Sharad S Singhal
Gynecological cancer tumor Microenvironment: Unveiling cellular complexity and therapeutic potential. Biochemical pharmacology 229 (2024)
Xiaoyong Huang, Qianqian Li, Shaobo Yun, Junhui Guo, Huiting Yang, Jianzhong Wang, Jia Cheng, Zilong Sun
Zn(II) enhances the antimicrobial effect of chloroxine and structural analogues against drug-resistant ESKAPE pathogens in vitro. Biochemical pharmacology 229 (2024)
Zhiqiang Ke, Qianqian Ma, Xiaonan Ye, Yanlin Wang, Yan Jin, Xinyuan Zhao, Zhengding Su
Peptide GLP-1 receptor agonists: From injection to oral delivery strategies. Biochemical pharmacology 229 (2024)
Nana Zhou, Chaoqin Guo, Xiangyu Li, Linglan Tu, Jingyang Du, Qiyi Qian, Juejiashan Li, Dongsheng Huang, Qiuran Xu, Xiaoliang Zheng
USP24 promotes hepatocellular carcinoma tumorigenesis through deubiquitinating and stabilizing TRAF2. Biochemical pharmacology 229 (2024)

volume 227, 2024

Chunying Luo, Guzhou Chen, Ruixiang Li, Shoujiao Peng, Pei Zhang, Feiyun Wang, Shaopeng Yu, Yuying Zhu, Jiange Zhang
Juglone suppresses vasculogenic mimicry in glioma through inhibition of HuR-mediated VEGF-A expression. Biochemical pharmacology 227 (2024)
Xiting Wang, Huan Luo, Xiaozhen Peng, Jinjun Chen
Spider and scorpion knottins targeting voltage-gated sodium ion channels in pain signaling. Biochemical pharmacology 227 (2024)
Kristof De Vos, Adamantios Mavrogiannis, Justina Clarinda Wolters, Susan Schlenner, Keimpe Wierda, Álvaro Cortés Calabuig, Reena Chinnaraj, Vera Dermesrobian, Yeghig Armoudjian, Maarten Jacquemyn, Nikky Corthout, Dirk Daelemans, Pieter Annaert
Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells. Biochemical pharmacology 227 (2024)
Xizhi Jin, Sijie Wang, Lihua Luo, Fangjie Yan, Qiaojun He
Targeting the Wnt/β-catenin signal pathway for the treatment of gastrointestinal cancer: Potential for advancement. Biochemical pharmacology 227 (2024)
Gao Fan, Yuchen Zhang, Qi Li, Rong Rong, Si Chen, Lexin He, Bingzong Li, Wenzhuo Zhuang
BCL6 confers resistance to HDAC inhibitors in DLBCL. Biochemical pharmacology 227 (2024)
Lu Jiang, Shaonan Yang, Ling Deng, Jingjing Luo, Xiaoling Zhang, Sha Chen, Zhi Dong
ARL13B promotes cell cycle through the sonic hedgehog signaling pathway to alleviate nerve damage during cerebral ischemia/reperfusion in rats. Biochemical pharmacology 227 (2024)
Stephanie M Anbuhl, Xavier Dervillez, Saskia Neubacher, Angela I Schriek, Vladimir Bobkov, Steven W de Taeye, Martyna Szpakowska, Marco Siderius, Tom N Grossmann, Andy Chevigné, Martine J Smit, Raimond Heukers
Multivalent CXCR4-targeting nanobody formats differently affect affinity, receptor clustering, and antagonism. Biochemical pharmacology 227 (2024)
Ying Jiang, Yanli Li, Yuzhu Wang, Xiaoyu Li
Furanodienone induces apoptosis via regulating the PRDX1/MAPKs/p53/caspases signaling axis through NOX4-derived mitochondrial ROS in colorectal cancer cells. Biochemical pharmacology 227 (2024)
Matome Imai, Shuang Liu, Akiko Yano, Yasuyuki Suzuki, Masaki Mogi, Takashi Sugiyama
Feasibility and efficacy of pemafibrate for prevention of maternal high-fat intake-induced glucose metabolic dysfunction in offspring. Biochemical pharmacology 227 (2024)
Rita B Soares, Joana Pinto, Filipa Amaro, Rita Manguinhas, Nuno Gil, Rafael Rosell, Ines Batinic-Haberle, Ana S Fernandes, Nuno G Oliveira, Paula Guedes de Pinho
Impact of the redox-active MnTnHex-2-PyP 5+ and cisplatin on the metabolome of non-small cell lung cancer cells. Biochemical pharmacology 227 (2024)
Kristof De Vos, Adamantios Mavrogiannis, Justina Clarinda Wolters, Susan Schlenner, Keimpe Wierda, Álvaro Cortés Calabuig, Reena Chinnaraj, Vera Dermesrobian, Yeghig Armoudjian, Maarten Jacquemyn, Nikky Corthout, Dirk Daelemans, Pieter Annaert
Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells. Biochemical pharmacology 227 (2024)